Neuronetics (STIM) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Neuronetics (STIM) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 16.91% |
| 10 | Neuronetics | 225.60 Mn | 206.17 Mn | 21.22 Mn | 82.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.02% |
| Mar 31, 2026 | 25.25% |
| Dec 31, 2025 | 56.13% |
| Sep 30, 2025 | 65.80% |
| Jun 30, 2025 | 80.34% |
| Mar 31, 2025 | -41.38% |
| Dec 31, 2024 | -81.37% |
| Sep 30, 2024 | 40.21% |
| Jun 30, 2024 | 44.98% |
| Mar 31, 2024 | 52.49% |
| Dec 31, 2023 | 62.26% |
| Sep 30, 2023 | -26.65% |
| Jun 30, 2023 | 3.00% |
| Mar 31, 2023 | -300.68% |
| Dec 31, 2022 | 15.31% |
| Sep 30, 2022 | -362.18% |
| Jun 30, 2022 | -2,065.63% |
| Mar 31, 2022 | -315.40% |
| Dec 31, 2021 | -215.24% |
| Sep 30, 2021 | -192.27% |